Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The need for a regen industry voice
Chris Mason, Peter Dunnill
Regenerative Medicine (2008) Vol. 3, Iss. 5, pp. 621-631
Closed Access | Times Cited: 14

Showing 14 citing articles:

Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
Chris Mason, David Brindley, Emily J Culme-Seymour, et al.
Regenerative Medicine (2011) Vol. 6, Iss. 3, pp. 265-272
Closed Access | Times Cited: 147
Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products
Iván Martín, Timothy P. L. Smith, David Wendt
Trends in biotechnology (2009) Vol. 27, Iss. 9, pp. 495-502
Open Access | Times Cited: 134
Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010
Chris Mason, Elisa Manzotti
Regenerative Medicine (2010) Vol. 5, Iss. 3, pp. 307-313
Closed Access | Times Cited: 109
On the Genealogy of Tissue Engineering and Regenerative Medicine
Himanshu Kaul, Yiannis Ventikos
Tissue Engineering Part B Reviews (2014) Vol. 21, Iss. 2, pp. 203-217
Open Access | Times Cited: 57
Regen: the industry responsible for cell-based therapies
Chris Mason, Elisa Manzotti
Regenerative Medicine (2009) Vol. 4, Iss. 6, pp. 783-785
Closed Access | Times Cited: 34
Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycle
Chris Mason, Elisa Manzotti
Regenerative Medicine (2009) Vol. 4, Iss. 3, pp. 329-331
Closed Access | Times Cited: 28
Challenges and opportunities in the manufacture and expansion of cells for therapy
Joachim Maartens, Elena M. De‐Juan‐Pardo, Felix M. Wunner, et al.
Expert Opinion on Biological Therapy (2017) Vol. 17, Iss. 10, pp. 1221-1233
Closed Access | Times Cited: 18
Management of Innovation in Academia: A Case Study in Tampere
Tuomo Heinonen
Journal of technology management & innovation (2015) Vol. 10, Iss. 2, pp. 198-210
Open Access | Times Cited: 9
ISSCR 2009 Industry Panel Session: Promoting Translation and Commercialization
Chris Mason
Cell stem cell (2009) Vol. 5, Iss. 4, pp. 379-384
Open Access | Times Cited: 10
Cell therapy commercialisation
David Brindley, Carl J. Mason
Elsevier eBooks (2012), pp. 169-205
Closed Access | Times Cited: 4
Regenerative Medicine as an Emergent Cluster in Tampere Region
Tuomo Heinonen, Francisco Javier Ortega-Colomer
Journal of Entrepreneurship Management and Innovation (2015) Vol. 11, Iss. 4, pp. 139-160
Open Access | Times Cited: 3
Governing Regenerative Medicine
Andrew Webster, Alex Faulkner
Palgrave Macmillan UK eBooks (2015), pp. 510-525
Closed Access | Times Cited: 1

Marta Gancarczyk, Jon Mikel Zabala‐Iturriagagoitia, Jon Zabala, et al.
Journal of Entrepreneurship Management and Innovation (2015) Vol. 11, Iss. 4
Open Access
Drug Delivery Aspects for Regenerative Therapies
Priyank R. Parikh, Farheen S. Badshah, Nikhita B. Prabhu, et al.
Indo Global Journal of Pharmaceutical Sciences (2013) Vol. 03, Iss. 02, pp. 107-123
Closed Access
Page 1

Scroll to top